Keck Medicine of USC enrolling volunteers for Phase 3 clinical trial for COVID-19 vaccine

Keck Medicine of USC is enrolling volunteers as part of a multicenter clinical trial sponsored by AstraZeneca to determine if an experimental vaccine known as AZD1222 provides protection against the coronavirus. The trial will Read More »

August 17th, 2020|Announcements, Clinical Studies, COVID-19, Keck Net Intranet|

Researchers enrolling patients in trials for a possible antiviral treatment for COVID-19

As the pandemic continues, physicians and researchers across the world are working doggedly to find ways to mitigate the toll of COVID-19, especially among populations experiencing infection surges. While many scientists are striving to create a vaccine, others Read More »

July 23rd, 2020|Announcements, Clinical Studies, COVID-19, Keck Net Intranet|

USC Norris Comprehensive Cancer Center receives $5 million for cancer drug discoveries

On June 29, USC Norris Comprehensive Cancer Center, Keck Medicine of USC and the Read More »

June 30th, 2020|Announcements, Clinical Studies, Keck Net Intranet|

Keck Medicine of USC launches clinical trial to study anti-inflammatory drug as treatment for COVID-19

Keck Medicine of USC physicians are launching a clinical trial to evaluate the efficacy and safety of baricitinib, an anti-inflammatory drug approved by the Food and Drug Read More »

May 6th, 2020|Announcements, Clinical Studies, COVID-19, Keck Net Intranet|

Keck School announces new prioritization process for COVID-19 research

The Keck School of Medicine of USC has established a process to rapidly evaluate research related to COVID-19 and open opportunities for care to clinicians and patients, according to a memo distributed April 4.

The new Read More »

April 13th, 2020|Announcements, Clinical Studies, COVID-19, Keck Net Intranet|